Affiliation:
1. Departments of Microbiology
2. Urology
3. Radiation Oncology
4. NYU Cancer Institute, NYU School of Medicine, 550 First Avenue, New York, New York 10016
Abstract
ABSTRACT
The cochaperone p23 plays an important role in estrogen receptor alpha (ER) signal transduction. In this study, we investigated how p23 regulates ER target gene activation and affects tumor growth and progression. Remarkably, we found that changes in the expression of p23 differentially affected the activation of ER target genes in a manner dependent upon the type of DNA regulatory element. p23 overexpression enhanced the expression of the ER target genes cathepsin D and pS2, which are regulated by direct DNA binding of ER to estrogen response elements (ERE). In contrast, the expression of other target genes, including c-Myc, cyclin D1, and E2F1, to which ER is recruited indirectly through its interaction with other transcription factors remains unaffected by changes in p23 levels. The p23-induced expression of pS2 is associated with enhanced recruitment of ER to the ERE in the promoter, whereas ER recruitment to the ERE-less c-Myc promoter does not respond to p23. Intriguingly, p23-overexpressing MCF-7 cells exhibit increased adhesion and invasion in the presence of fibronectin. Our findings demonstrate that p23 differentially regulates ER target genes and is involved in the control of distinct cellular processes in breast tumor development, thus revealing novel functions of this cochaperone.
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology
Reference36 articles.
1. Bagatell, R., O. Khan, G. Paine-Murrieta, C. W. Taylor, S. Akinaga, and L. Whitesell. 2001. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Clin. Cancer Res.7:2076-2084.
2. Beliakoff, J., R. Bagatell, G. Paine-Murrieta, C. W. Taylor, A. E. Lykkesfeldt, and L. Whitesell. 2003. Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors. Clin. Cancer Res.9:4961-4971.
3. Boxer, L. M., and C. V. Dang. 2001. Translocations involving c-myc and c-myc function. Oncogene20:5595-5610.
4. Burrows, F., H. Zhang, and A. Kamal. 2004. Hsp90 activation and cell cycle regulation. Cell Cycle3:1530-1536.
5. Chiosis, G., M. Vilenchik, J. Kim, and D. Solit. 2004. Hsp90: the vulnerable chaperone. Drug Discov. Today9:881-888.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献